$RETA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REATA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REATA PHARMACEUTICALS INC. Get notifications about new insider transactions in REATA PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 21.37 | 670 | 14,315 | 260,146 | 259.5 K to 260.1 K (+0.26 %) | |
Dec 16 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 22.05 | 2,700 | 59,534 | 1,751,889 | 1.7 M to 1.8 M (+0.15 %) | |
Dec 16 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 21.37 | 6,189 | 132,229 | 1,749,189 | 1.7 M to 1.7 M (+0.36 %) | |
Dec 16 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 22.05 | 2,700 | 59,534 | 1,751,889 | 1.7 M to 1.8 M (+0.15 %) | |
Dec 16 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 21.37 | 6,189 | 132,229 | 1,749,189 | 1.7 M to 1.7 M (+0.36 %) | |
Dec 15 2016 | RETA | REATA PHARMACEUTIC ... | Bass James Edward | Director | Buy | P | 21.76 | 5,000 | 108,800 | 30,585 | 25.6 K to 30.6 K (+19.54 %) |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Option Exercise | A | 22.57 | 2,773 | 62,587 | 2,773 | ||
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Option Exercise | A | 22.57 | 6,000 | 135,420 | 6,000 | ||
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | A | 22.57 | 62,800 | 1,417,396 | 62,800 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | Chief Financial Off ... | Option Exercise | A | 22.57 | 65,000 | 1,467,050 | 65,000 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Ward Keith Wayne | Chief Development O ... | Option Exercise | A | 22.57 | 85,000 | 1,918,450 | 85,000 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Stone Dennis K. | Director | Option Exercise | A | 22.57 | 6,000 | 135,420 | 6,000 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Option Exercise | A | 22.57 | 90,000 | 2,031,300 | 90,000 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Huff James Warren | Chief Executive Off ... | Option Exercise | A | 22.57 | 199,900 | 4,511,743 | 199,900 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | Principal Accountin ... | Option Exercise | A | 22.57 | 27,000 | 609,390 | 27,000 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Bir Dawn Carter | VP, Chief Commercia ... | Option Exercise | A | 22.57 | 40,000 | 902,800 | 40,000 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Bass James Edward | Director | Option Exercise | A | 22.57 | 632 | 14,264 | 632 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | Bass James Edward | Director | Option Exercise | A | 22.57 | 6,000 | 135,420 | 6,000 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | A | 22.57 | 1,758 | 39,678 | 1,758 | |
Dec 08 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | A | 22.57 | 6,000 | 135,420 | 6,000 | |
Aug 24 2016 | RETA | REATA PHARMACEUTIC ... | Nielsen Jack | Director | Buy | P | 17.00 | 1,780 | 30,260 | 1,780 | 0 to 1.8 K |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.32 | 34,130 | 591,234 | 288,102 | 254 K to 288.1 K (+13.44 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.32 | 35,490 | 614,793 | 239,587 | 204.1 K to 239.6 K (+17.39 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.32 | 23,530 | 407,610 | 198,682 | 175.2 K to 198.7 K (+13.43 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.32 | 4,120 | 71,371 | 108,285 | 104.2 K to 108.3 K (+3.96 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.32 | 6,470 | 112,080 | 54,631 | 48.2 K to 54.6 K (+13.43 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.32 | 1,822 | 31,563 | 36,359 | 34.5 K to 36.4 K (+5.28 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.26 | 46,510 | 802,884 | 253,972 | 207.5 K to 254 K (+22.42 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.26 | 48,320 | 834,129 | 204,097 | 155.8 K to 204.1 K (+31.02 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.26 | 32,080 | 553,784 | 175,152 | 143.1 K to 175.2 K (+22.42 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.26 | 5,830 | 100,641 | 104,165 | 98.3 K to 104.2 K (+5.93 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.26 | 8,820 | 152,256 | 48,161 | 39.3 K to 48.2 K (+22.42 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.26 | 2,498 | 43,122 | 34,537 | 32 K to 34.5 K (+7.80 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 16.21 | 18,620 | 301,845 | 207,462 | 188.8 K to 207.5 K (+9.86 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 16.21 | 19,050 | 308,816 | 155,777 | 136.7 K to 155.8 K (+13.93 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 16.21 | 12,840 | 208,147 | 143,072 | 130.2 K to 143.1 K (+9.86 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 16.21 | 3,460 | 56,089 | 98,335 | 94.9 K to 98.3 K (+3.65 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 16.21 | 3,530 | 57,224 | 39,341 | 35.8 K to 39.3 K (+9.86 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 16.21 | 1,100 | 17,832 | 32,039 | 30.9 K to 32 K (+3.56 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 17.32 | 105,562 | 1,828,651 | 1,743,000 | 1.6 M to 1.7 M (+6.45 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 17.26 | 144,058 | 2,486,816 | 1,637,438 | 1.5 M to 1.6 M (+9.65 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 16.21 | 58,600 | 949,953 | 1,493,380 | 1.4 M to 1.5 M (+4.08 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 17.32 | 105,562 | 1,828,651 | 1,743,000 | 1.6 M to 1.7 M (+6.45 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 17.26 | 144,058 | 2,486,816 | 1,637,438 | 1.5 M to 1.6 M (+9.65 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 16.21 | 58,600 | 949,953 | 1,493,380 | 1.4 M to 1.5 M (+4.08 %) | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | W | 0.00 | 87,776 | 0 | 87,776 | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | W | 0.00 | 87,776 | 0 | 0 | |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | W | 0.00 | 7,886 | 0 | 7,886 | 0 to 7.9 K |
Aug 18 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Sell | W | 0.00 | 7,886 | 0 | 0 | 7.9 K to 0 (-100.00 %) |
Aug 17 2016 | RETA | REATA PHARMACEUTIC ... | Meyer Colin John | Chief Medical Offic ... | Buy | P | 16.26 | 7,000 | 113,820 | 27,172 | 20.2 K to 27.2 K (+34.70 %) |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 19.75 | 100,000 | 1,975,110 | 632,780 | 532.8 K to 632.8 K (+18.77 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 19.83 | 63,700 | 1,263,056 | 532,780 | 469.1 K to 532.8 K (+13.58 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 19.74 | 900 | 17,763 | 469,080 | 468.2 K to 469.1 K (+0.19 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 19.75 | 100,000 | 1,975,110 | 632,780 | 532.8 K to 632.8 K (+18.77 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 19.83 | 63,700 | 1,263,056 | 532,780 | 469.1 K to 532.8 K (+13.58 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 19.74 | 900 | 17,763 | 469,080 | 468.2 K to 469.1 K (+0.19 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.75 | 34,010 | 671,735 | 88,920 | 54.9 K to 88.9 K (+61.94 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.75 | 24,630 | 486,470 | 64,370 | 39.7 K to 64.4 K (+61.98 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.75 | 23,460 | 463,361 | 61,320 | 37.9 K to 61.3 K (+61.97 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.75 | 5,880 | 116,136 | 30,163 | 24.3 K to 30.2 K (+24.21 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.75 | 6,450 | 127,395 | 16,860 | 10.4 K to 16.9 K (+61.96 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.75 | 5,570 | 110,014 | 14,573 | 9 K to 14.6 K (+61.87 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.83 | 21,690 | 430,074 | 54,910 | 33.2 K to 54.9 K (+65.29 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.83 | 15,700 | 311,303 | 39,740 | 24 K to 39.7 K (+65.31 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.83 | 14,960 | 296,630 | 37,860 | 22.9 K to 37.9 K (+65.33 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.83 | 3,690 | 73,166 | 24,283 | 20.6 K to 24.3 K (+17.92 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.83 | 4,110 | 81,494 | 10,410 | 6.3 K to 10.4 K (+65.24 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.83 | 3,550 | 70,390 | 9,003 | 5.5 K to 9 K (+65.10 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.74 | 310 | 6,119 | 33,220 | 32.9 K to 33.2 K (+0.94 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.74 | 220 | 4,342 | 24,040 | 23.8 K to 24 K (+0.92 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.74 | 210 | 4,145 | 22,900 | 22.7 K to 22.9 K (+0.93 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.74 | 50 | 987 | 20,593 | 20.5 K to 20.6 K (+0.24 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.74 | 60 | 1,184 | 6,300 | 6.2 K to 6.3 K (+0.96 %) | |
Jun 30 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.74 | 50 | 987 | 5,453 | 5.4 K to 5.5 K (+0.93 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 19.17 | 21,968 | 421,234 | 468,180 | 446.2 K to 468.2 K (+4.92 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 19.17 | 21,968 | 421,234 | 468,180 | 446.2 K to 468.2 K (+4.92 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 19.49 | 42,526 | 828,853 | 446,212 | 403.7 K to 446.2 K (+10.53 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 19.49 | 42,526 | 828,853 | 446,212 | 403.7 K to 446.2 K (+10.53 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 18.35 | 8,909 | 163,481 | 403,686 | 394.8 K to 403.7 K (+2.26 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 18.35 | 8,909 | 163,481 | 403,686 | 394.8 K to 403.7 K (+2.26 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 19.17 | 21,968 | 421,234 | 468,180 | 446.2 K to 468.2 K (+4.92 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 19.17 | 21,968 | 421,234 | 468,180 | 446.2 K to 468.2 K (+4.92 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 19.49 | 42,526 | 828,853 | 446,212 | 403.7 K to 446.2 K (+10.53 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 19.49 | 42,526 | 828,853 | 446,212 | 403.7 K to 446.2 K (+10.53 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 18.35 | 8,909 | 163,481 | 403,686 | 394.8 K to 403.7 K (+2.26 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 18.35 | 8,909 | 163,481 | 403,686 | 394.8 K to 403.7 K (+2.26 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.17 | 6,770 | 129,814 | 259,476 | 252.7 K to 259.5 K (+2.68 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.17 | 5,130 | 98,367 | 32,190 | 27.1 K to 32.2 K (+18.96 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.17 | 3,720 | 71,331 | 23,820 | 20.1 K to 23.8 K (+18.51 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.17 | 3,540 | 67,879 | 22,690 | 19.2 K to 22.7 K (+18.49 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.17 | 990 | 18,983 | 20,543 | 19.6 K to 20.5 K (+5.06 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.17 | 970 | 18,600 | 6,240 | 5.3 K to 6.2 K (+18.41 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.17 | 848 | 16,260 | 5,403 | 4.6 K to 5.4 K (+18.62 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.49 | 14,386 | 280,390 | 27,780 | 13.4 K to 27.8 K (+107.41 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.49 | 10,418 | 203,052 | 20,100 | 9.7 K to 20.1 K (+107.60 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.49 | 9,921 | 193,365 | 19,150 | 9.2 K to 19.2 K (+107.50 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.49 | 2,712 | 52,858 | 19,553 | 16.8 K to 19.6 K (+16.10 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.49 | 2,728 | 53,170 | 5,270 | 2.5 K to 5.3 K (+107.32 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 19.49 | 2,360 | 45,998 | 4,555 | 2.2 K to 4.6 K (+107.52 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 18.35 | 3,014 | 55,307 | 13,394 | 10.4 K to 13.4 K (+29.04 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 18.35 | 2,182 | 40,040 | 9,682 | 7.5 K to 9.7 K (+29.09 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 18.35 | 2,079 | 38,150 | 9,229 | 7.2 K to 9.2 K (+29.08 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 18.35 | 568 | 10,423 | 16,841 | 16.3 K to 16.8 K (+3.49 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 18.35 | 572 | 10,496 | 2,542 | 2 K to 2.5 K (+29.04 %) | |
Jun 28 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 18.35 | 495 | 9,083 | 2,195 | 1.7 K to 2.2 K (+29.12 %) | |
Jun 13 2016 | RETA | REATA PHARMACEUTIC ... | Stapleton Pharma LLC | Sell | J | 0.00 | 420,000 | 0 | 32,864 | 452.9 K to 32.9 K (-92.74 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 17.62 | 4,220 | 74,360 | 394,777 | 390.6 K to 394.8 K (+1.08 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 17.56 | 20,000 | 351,192 | 390,557 | 370.6 K to 390.6 K (+5.40 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.62 | 1,400 | 24,669 | 10,380 | 9 K to 10.4 K (+15.59 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.62 | 1,010 | 17,797 | 7,500 | 6.5 K to 7.5 K (+15.56 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.62 | 970 | 17,092 | 7,150 | 6.2 K to 7.2 K (+15.70 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.62 | 340 | 5,991 | 16,273 | 15.9 K to 16.3 K (+2.13 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.62 | 270 | 4,758 | 1,970 | 1.7 K to 2 K (+15.88 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.62 | 230 | 4,053 | 1,700 | 1.5 K to 1.7 K (+15.65 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.56 | 6,650 | 116,771 | 8,980 | 2.3 K to 9 K (+285.41 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.56 | 4,810 | 84,462 | 6,490 | 1.7 K to 6.5 K (+286.31 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.56 | 4,580 | 80,423 | 6,180 | 1.6 K to 6.2 K (+286.25 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.56 | 1,610 | 28,271 | 15,933 | 14.3 K to 15.9 K (+11.24 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.56 | 1,260 | 22,125 | 1,700 | 440 to 1.7 K (+286.36 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 17.56 | 1,090 | 19,140 | 1,470 | 380 to 1.5 K (+286.84 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 17.62 | 4,220 | 74,360 | 394,777 | 390.6 K to 394.8 K (+1.08 %) | |
Jun 08 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 17.56 | 20,000 | 351,192 | 390,557 | 370.6 K to 390.6 K (+5.40 %) | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 13.42 | 625 | 8,387 | 57,974 | 57.3 K to 58 K (+1.09 %) | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 13.42 | 830 | 11,139 | 14,323 | 13.5 K to 14.3 K (+6.15 %) | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 13.42 | 2,330 | 31,268 | 2,330 | 0 to 2.3 K | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 13.42 | 1,680 | 22,545 | 1,680 | 0 to 1.7 K | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 13.42 | 1,600 | 21,472 | 1,600 | 0 to 1.6 K | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 13.42 | 440 | 5,905 | 440 | 0 to 440 | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 13.42 | 380 | 5,100 | 380 | 0 to 380 | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | CPMG Inc | Buy | P | 13.42 | 150 | 2,013 | 150 | 0 to 150 | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | Traweek James W JR | Buy | P | 13.42 | 8,035 | 107,829 | 370,557 | 362.5 K to 370.6 K (+2.22 %) | |
Jun 03 2016 | RETA | REATA PHARMACEUTIC ... | McGaughy R Kent Jr | Buy | P | 13.42 | 8,035 | 107,829 | 370,557 | 362.5 K to 370.6 K (+2.22 %) | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | Novo A/S | 10% Owner | Buy | P | 11.00 | 750,000 | 8,250,000 | 750,000 | 0 to 750 K |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | C | 0.00 | 45 | 0 | 492 | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | C | 0.00 | 20 | 0 | 215 | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | C | 0.00 | 29 | 0 | 313 | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | C | 0.00 | 1,426 | 0 | 15,869 | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | C | 0.00 | 7,886 | 0 | 87,776 | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | C | 0.00 | 168,720 | 0 | 1,877,998 | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Option Exercise | C | 0.00 | 11,618 | 0 | 129,308 | |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | P | 11.00 | 143,000 | 1,573,000 | 143,000 | 0 to 143 K |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | P | 11.00 | 957,000 | 10,527,000 | 957,000 | 0 to 957 K |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | C | 0.00 | 45 | 0 | 45 | 0 to 45 |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | C | 0.00 | 20 | 0 | 20 | 0 to 20 |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | C | 0.00 | 29 | 0 | 29 | 0 to 29 |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | C | 0.00 | 1,426 | 0 | 1,426 | 0 to 1.4 K |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | C | 0.00 | 7,886 | 0 | 7,886 | 0 to 7.9 K |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | C | 0.00 | 168,720 | 0 | 168,720 | 0 to 168.7 K |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | ROSE WILLIAM | Director | Buy | C | 0.00 | 11,618 | 0 | 11,618 | 0 to 11.6 K |
Jun 02 2016 | RETA | REATA PHARMACEUTIC ... | Wilson Jason Douglas | See Remarks | Option Exercise | C | 0.00 | 5,770 | 0 | 64,699 |